Mo1891 EPIGENETIC REGULATION OF INTESTINAL STEM CELLS BY THE FUNCTIONAL PEPTIDE OF A PROBIOTIC-DERIVED PROTEIN FOR LONG-TERM PREVENTION OF COLITIS

Tu1826 IMPACT OF GLP-1 RECEPTOR AGONIST ON CLINICAL OUTCOMES IN PATIENTS WITH CROHN'S DISEASE AND ULCERATIVE COLITIS: INSIGHTS FROM A LARGE-SCALE ...

Mo1848 UPADACITINIB IS EFFECTIVE AND SAFE FOR THE TREATMENT OF ULCERATIVE COLITIS AND CROHN'S DISEASE: 1-YEAR PROSPECTIVE REAL-WORLD EXPERIENCE

Sa1835 LOW SERUM URIC ACID LEVES ARE ASSOCIATED WITH LOW BONE MINERAL DENSITY IN MALE PATIENTS WITH ULCERATIVE COLITIS

Tu1765 MUCOSAL IGG-LIKE NAIVE B-CELL EXPANSION AND MATURATION CONTRIBUTE TO ULCERATIVE COLITIS PATHOGENESIS

Tu1865 ASSESSING PATIENT-PERCEIVED BURDEN OF DISEASE IN ULCERATIVE COLITIS: A NOVEL SCORING APPROACH IN A REAL-WORLD AUSTRALASIAN COHORT

Tu1914 OFFICE-BASED FLEXIBLE SIGMOIDOSCOPY ALLOWS RAPID ASSESSMENT AND MANAGEMENT OF SUSPECTED IMMUNE CHECKPOINT INHIBITOR-RELATED COLITIS

116 DIETARY FIBER-INDUCED ODORIBACTER METABOLITES PROMOTE MUCOSAL HEALING IN COLITIS

108 TIGHT JUNCTION PLAYS AN ESSENTIAL ROLE IN IMMUNOTHERAPYINDUCED COLITIS AND TUMOR PROGRESSION

Tu1890 CLINICAL EFFICACY OF GRANULOCYTE AND MONOCYTE APHERESIS (GMA) IN ULCERATIVE COLITIS. THE EXPERIENCE OF FOUR TERTIARY CENTERS.